Pharma Journalist - Page 868 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Ligand Enters Into Worldwide OmniAb Platform License Agreement With xCella Biosciences

New research into delaying the onset of motor neurone disease shows positive results

AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee

TaiGen Biotechnology submits NDA for Taigexyn Intravenous Formulation to CFDA

BioPharma Services completes 3 FDA Inspections at both the research centers

Bluebee and MediSapiens enters a partnership to provide comprehensive integrated solution for NGS

Compugen appoints Dr. Michal Preminger to Board of Directors

Recipharm appoints Shabbir Mostafa as Director, Business Management UK & Ireland

Avista Pharma and MMRF partners to produce conjugate vaccine to combat substance abuse

Hovione to initiate HY02 Phase 1 Clinical Trial